Asthma Guidelines Priority Topics: Intermittent Inhaled Corticosteroid Therapy and Inhaled Corticosteroids with Long...

Area of Science:

• Pulmonology
• Pediatric Asthma Management
• Pharmacotherapy

Background:

• Asthma management guidelines require regular updates based on emerging evidence.
• Intermittent inhaled corticosteroid (ICS) therapy is a common treatment approach for asthma.
• Long-acting beta-agonists (LABAs) are often used in conjunction with other asthma medications.

Purpose of the Study:

• To evaluate the effectiveness of intermittent inhaled corticosteroid (ICS) therapy compared to ICS with long-acting beta-agonist (LABA) therapy.
• To provide evidence-based recommendations for asthma diagnosis and management.
• To update guidelines for children aged 0-4 years and individuals aged 5 years and older.

Main Methods:

• Systematic review of clinical studies on asthma pharmacotherapy.
• Analysis of treatment effectiveness in different age groups (pediatric and adult).
• Assessment of intermittent ICS monotherapy versus combination therapy with LABAs.

Main Results:

• Findings on the comparative effectiveness of intermittent ICS and ICS/LABA therapy are summarized.
• Evidence is presented for specific age cohorts, including young children and older individuals.
• The review informs updates to the National Asthma Education and Prevention Program guidelines.

Conclusions:

• The study provides critical data for updating asthma management protocols.
• Recommendations are based on the efficacy of different inhaled corticosteroid regimens.
• The findings aim to improve asthma control and patient outcomes across age groups.